Carbohydrate-loading fluid: Pulp-free clear apple juice (Cappy® Apple Juice, 200 mL pack, 10% sugar, 48 kcal/100 mL; Coca-Cola, Türkiye) will be administered as an oral carbohydrate drink at a dose of 5 mL/kg, 2 hours before surgery (maximum volume: 200 mL)
Sip-till-send clear fluid: Patients will consume small sips of clear fluids (pulp-free clear apple juice \[Cappy® Apple Juice, 200 mL pack, 10% sugar, 48 kcal/100 mL; Coca-Cola, Türkiye\] and water) approximately every 60 minutes after midnight until they are called to the operating room (maximum total volume 10 mL/kg).
Study summary
Children who undergo surgery are usually asked to stop eating and drinking for several hours before anesthesia to reduce the risk of stomach contents entering the lungs. However, long fasting times may cause discomfort, dehydration, low blood sugar, and increased anxiety in children. Recent guidelines suggest that clear liquids can safely be allowed closer to the time of surgery, and some enhanced recovery protocols even recommend giving carbohydrate-containing drinks before anesthesia.
This study will compare three different preoperative fasting approaches in children undergoing elective inguinoscrotal surgery: traditional fasting, preoperative carbohydrate drinks, and the "Sip-Til-Send" approach, which allows clear fluids until the child is called to the operating room.
The children's anxiety levels will be evaluated before surgery using a validated anxiety scale and assess stomach content and volume using gastric ultrasound. The secondary outcomes such as nausea, vomiting, pain, emergence delirium, and blood glucose levels will be evaluated.
The results may help determine safer and more comfortable fasting strategies for children undergoing surgery.
Eligibility
Sex
ALL
Min age
2 Years
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients scheduled to undergo elective surgery under general anesthesia for circumcision, undescended testis, inguinal hernia, and/or hypospadias (inguinoscrotal surgery)
* Patients with an ASA physical status classification of I-II
* Patients able to tolerate oral intake in the preoperative period and comply with the assigned fasting protocol
* Written informed consent obtained from parents or legal guardians
Exclusion Criteria:
* Patients with ASA physical status III or higher
* Patients requiring emergency surgery
* History of gastroesophageal reflux disease, gastrointestinal motility disorders, or metabolic/neurological diseases affecting gastric emptying
* History of upper gastrointestinal surgery
* Active upper respiratory tract infection or lower respiratory tract infection within the previous 2-4 weeks
* Severe pulmonary disease, including uncontrolled or moderate-to-severe persistent asthma, bronchopulmonary dysplasia, cystic fibrosis, interstitial lung disease, or other chronic lung diseases
* Diabetes mellitus or endocrine/metabolic disorders that may affect perioperative glucose metabolism
* Obese patients with high aspiration risk (\>95th percentile for age)
* Cognitive or communication impairments that may interfere with compliance with the study protocol
* Grade 2 or Grade 3 gastric fullness detected on preoperative gastric ultrasonography
* Lack of written informed consent from parents or legal guardians for participation in the study
Primary outcome measure(s)
Anxiety — postoperative 1st hour Anxiety will be assessed using the Modified Yale Preoperative Anxiety Scale (m-YPAS). The m-YPAS consists of five domains: (1) activity, (2) vocalizations, (3) emotional expressivity, (4) state of apparent arousal, and (5) use of a parent. Each domain is scored from 1 to 4, where 1 represents the lowest level and 4 the highest level of anxiety-related behavior. A total m-YPAS score \>30 will be considered indicative of high anxiety.
Trial sites (2)
Facility
City
Region
Status
University of Health Sciences, Bursa City Hospital
Bursa
Bursa
Active Not Recruiting
University of Health Sciences, Bursa City Hospital
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.